In the sphere of immuno-oncology research, a powerful tool has emerged - the Diet-Induced Obesity (DIO) mouse model. These models provide researchers a practical route to understanding the connections between obesity, immunity, and cancer treatment. The real value of DIO mice lies in their ability to reflect human-like responses, marking a new phase of discovery. Below are the top 5 reasons researchers should be incorporating DIO mice into the preclinical evaluation of immuno-oncology treatments.
Unveiling the Potential: 5 Ways DIO Mice Enhance Immuno-Oncology Discoveries
August 22, 2023
Immunophenotyping Pig Immune Cells by Flow Cytometry
By Jennifer J. Stewart, PhD
The Thing About Theranostics…
The landscape of oncology drug development is rapidly evolving, with personalized medicine taking center stage. At the heart of this revolution is ...
American Association of Pharmaceutical Scientists (AAPS) Flow Cytometry Action Programming Committee
By Jennifer J. Stewart, PhD
Get Started
Contact Us Today!
If you’re looking for an expert team to guide your trial with efficiency in mind, we can help. As the creators of the Dynamic Trial, TD2 provides start-to-finish support with trial strategy, design and execution for faster go-to-market potential.